Martin Welschof
Board member
Therapeutics
Nextera
Germany
Biography
Dr. Martin Welschof joined the board of Nextera in 2013. Dr. Welschof is currently the CEO for Opsona Therapeutics in Dublin/Ireland. Martin is an entrepreneurial, senior executive with extensive experience in launching and building successful businesses focused on drug development and drug discovery platforms. Before joining Opsona Therapeutics in 2012, Martin Welschof was the Managing Director and co-founder of Affitech A/S in Oslo/Norway and Copenhagen/Denmark. Prior to joining Affitech A/S, Dr. Welschof was the Director of Technology at Axaron Bioscience AG, Heidelberg, Germany. During his period at Axaron he worked also in the parent company of Axaron Bioscience, LYNX Therapeutics Inc. in Hayward California. Martin holds a Ph.D. in the field of recombinant antibody technology from the University of Bielefeld, Germany.
Research Interest
Drug Development and Drug Discovery.
